Technology And Equipment Tenders

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Baricitinib, (Obo) Atc L04aa37 for the Period February 1St, 2025 - January 31St, 2027

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Peg-Epoetin Beta, (Obo) Atc B03xa03 for the Period February 1St, 2025 - January 31St, 2027

Open House Drug Discount Agreements Buserelin, Atc L02ae01

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Flupentixol, (Obg) Atc N05af01 for the Period February 1St, 2025 - January 31St, 2027

Open House Drug Discount Agreements Tapentadol in the Non-Sustained-Release Dosage Forms, Atc N02ax06

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Mepolizumab, (Obo) Atc R03dx09 for the Period February 1St, 2025 - January 31St, 2027

Open House Drug Discount Agreements Trientin, Atc A16ax12

Dynamic Procurement System for Carpentry Work for Various Properties in Berlin

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Aripiprazole (Excl. Dafo for the Production of a Dis), (Obo) Atc N05ax12 for the Period February 1St, 2025 - January 31St,...

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Lipegfilgrastim, (Obo) Atc L03aa14 for the Period February 1St, 2025 - January 31St, 2027